Skip to main content

Viewpoint: To stay on top, Boston must lead pharma’s transformation

What it will really take for Boston to stay on top as a biotech hub is more than edging out other cities. It will take a visionary understanding of the seismic shift that pharmaceutical companies are about to undergo.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.